Arkolith/Insider Trading/INVO/Form 4

Doody Kevin

Medical Director, DirectorINVO Bioscience, Inc. (INVO) · full profile →Form 4 · filed Jun 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$168K
Net Open-Market Flow
-$168K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2022Sell(P)177K$0.95$168K0

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-015904) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for INVO Bioscience, Inc.

Build

Ask your agent about INVO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-22-015904"
Ask your agent
Use Arkolith to summarize insider buying and selling at INVO Bioscience, Inc.
over the last 90 days and cite the filings.